Business UpdateNov 12, 2026, 04:38 PM
Olema Pharmaceuticals Changes Name to Olema Oncology, Inc.
AI Summary
Olema Pharmaceuticals, Inc. has officially changed its corporate name to Olema Oncology, Inc., effective November 12, 2026. This change was filed with the Secretary of State of Delaware through an Eighth Amended and Restated Certificate of Incorporation. Stockholder approval was not required for this name change. The company also announced the relocation of its principal executive offices to South San Francisco, CA. The common stock will continue to trade under the ticker symbol "OLMA" on The Nasdaq Global Select Market.
Key Highlights
- Olema Pharmaceuticals, Inc. officially changed its name to Olema Oncology, Inc. effective November 12, 2026.
- The company filed its Eighth Amended and Restated Certificate of Incorporation to reflect the name change.
- Stockholder approval was not required for the name change, as per Delaware General Corporation Law.
- The company's common stock will continue to trade under the ticker symbol "OLMA" on The Nasdaq Global Select Market.
- Olema Oncology, Inc. relocated its principal executive offices to South San Francisco, CA.
Price Impact
More from OLMA